PE/TR Anti-Human CD83 Antibody[HB15e]

Introducing the PE/TR Anti-Human CD83 Antibody [HB15E], a highly specialized and meticulously crafted product designed to facilitate advanced research in the field of immunology. This antibody, meticulously developed by our team of expert scientists, offers an exceptional level of specificity and sensitivity, making it an invaluable tool for the investigation of CD83 expression in human samples.

The PE/TR Anti-Human CD83 Antibody [HB15E] is meticulously manufactured using cutting-edge technology and adheres to the highest quality standards. Its unique formulation ensures optimal performance and reliability, enabling accurate and reproducible results in a wide range of applications, including flow cytometry and immunohistochemistry.

This antibody exhibits exceptional binding affinity to the CD83 antigen, a crucial marker for dendritic cell maturation and activation. By targeting CD83, researchers can gain valuable insights into the intricate mechanisms underlying immune responses and the development of immunotherapeutic strategies.

With its dual labeling of PE and TR, this antibody offers enhanced versatility and flexibility in experimental design. The PE fluorochrome provides bright and distinct signals, while the TR fluorochrome allows for multiplexing with other fluorochromes, enabling simultaneous detection of multiple targets within a single sample.

The PE/TR Anti-Human CD83 Antibody [HB15E] is supplied in a convenient and user-friendly format, ensuring ease of use and compatibility with various laboratory protocols. Its exceptional stability and long shelf life guarantee consistent performance, minimizing the need for frequent reordering and ensuring cost-effectiveness.

In summary, the PE/TR Anti-Human CD83 Antibody [HB15E] represents a pinnacle of scientific excellence, offering researchers an indispensable tool for unraveling the complexities of the immune system. With its exceptional specificity, sensitivity, and versatility, this antibody is poised to revolutionize immunological research and contribute to the advancement of medical knowledge.